Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Radiation Injuries × Immunotherapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 3 Melanoma 2 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Recurrence 1 Radiation Injuries 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Bites and Stings 1

Interventions

Radiotherapy, Intensity-Modulated 3 Diet Therapy 3 Blood Specimen Collection 3 Radiotherapy 2 Radiosurgery 2 endostar protein 1 Xylitol 1 Surgical Procedures, Operative 1 Sildenafil Citrate 1 Serotonin Plasma Membrane Transport Proteins 1 Saline Solution 1 S 1 (combination) 1 Radiation Dose Hypofractionation 1 Proton Therapy 1 Probiotics 1 Oral Hygiene 1 Mental Status and Dementia Tests 1 Menogaril 1 Magnetic Resonance Spectroscopy 1 Lymph Node Excision 1 Low-Level Light Therapy 1 Immunotherapy 1 Hyperbaric Oxygenation 1 Heart Rate 1 Fatty Acids, Omega-3 1 Electroacupuncture 1 Early Intervention, Educational 1 Dexamethasone 1 Brachytherapy 1 Betaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07396116 2026-02-12

FUSION-02

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting

Radiation Injuries, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡